TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmor AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,840
|
2,473
|
1,991 |
| Financial expenses |
33
|
213
|
292 |
| Earnings before taxes |
958
|
1,078
|
617 |
| EBITDA |
852
|
1,102
|
869 |
| Total assets |
4,432
|
3,885
|
3,048 |
| Current assets |
868
|
986
|
1,268 |
| Current liabilities |
683
|
682
|
611 |
| Equity capital |
3,445
|
2,915
|
2,199 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.7%
|
75.0%
|
72.1% |
| Turnover per employee |
1,840
|
2,473
|
1,991 |
| Profit as a percentage of turnover |
52.1%
|
43.6%
|
31.0% |
| Return on assets (ROA) |
22.4%
|
33.2%
|
29.8% |
| Current ratio |
127.1%
|
144.6%
|
207.5% |
| Return on equity (ROE) |
27.8%
|
37.0%
|
28.1% |
| Change turnover |
-551
|
472
|
123 |
| Change turnover % |
-23%
|
24%
|
7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.